Public - Diabetes Mellitus, Type 1

Author: Maureen D. Passaro, MD; Robert E. Ratner, MD
Editorial changes - 2012-04-30
Author information and module status

Diabetes Mellitus, Type 1

	Prevention
	Screening
	Diagnosis
	Consultation for Diagnosis
	Hospitalization
	Therapy
	Patient Education
	Consultation for Management
	Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Quality Measures

What's New

ACP Members can access the full PIER website.
	New Reference of Interest	2012-04-21
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
	Alert	2012-04-20
FDA Safety Alert for Aliskiren-containing Medications: Drug Safety Communication - New Warning and Contraindication
	New Reference of Interest	2012-02-02
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.
	New Reference of Interest	2012-01-23
Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative.
	New Reference of Interest	2012-01-07
Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study.
	Annals Link	2012-01-03
Evaluation of Guideline Recommendations on Oral Medications for Type 2 Diabetes Mellitus
	New Reference of Interest	2012-01-01
Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline.
more>>

FAQs

Abd A. Tahrani, MD, MRCP, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Maureen D. Passaro, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Robert E. Ratner, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.

PIER is copyrighted © 2012 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.